{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:35Z","timestamp":1753892015433,"version":"3.41.2"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1707405"],"award-info":[{"award-number":["2018YFC1707405"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Kanglaite injection (KLTI) is a traditional Chinese medicine (TCM) preparation with anti-tumor activity, which has been used to treat malignant tumors in China. The purpose of this study was to evaluate the efficacy and safety of intrapleural infusion with KLTI in the treatment of malignant pleural effusion (MPE).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Randomized controlled trials (RCTs) on the efficacy and safety of intrathoracic infusion with KLTI in the treatment of MPE were searched from the PubMed, EMBASE, the Cochrane Library, CNKI, VIP, Wanfang and CBM databases. The primary outcome was objective remission rate (ORR). Secondary outcomes included quality of life (QOL) and incidence of adverse events (AEs). The Stata15.1 software and RevMan5.3 software were used to calculate risk ratios (RR) at 95% confidence intervals (CI) and conduct the meta-analysis.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> This meta-analysis included 20 RCTs, involving 1,291 patients. The ORR of intrapleural infusion with KLTI + chemotherapy drugs in the treatment of MPE was higher than that of chemotherapy alone (RR) 1.23; 95%CI; 1.11\u20131.36, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%, <jats:italic>z<\/jats:italic> = 3.876, <jats:italic>p<\/jats:italic> = 0.000]. When KLTI is combined with cisplatin or KLTI 200\u00a0ml is used in every time, it is more advantageous to improve ORR. Moreover, compared with intrapleural infusion of chemotherapy drugs alone, KLTI combined with chemotherapy drugs significantly improved the QOL of patients with MPE (RR 1.28; 95%CI; 1.70\u20131.53, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%, <jats:italic>z<\/jats:italic> = 2.70, <jats:italic>p<\/jats:italic> = 0.007). In addition, the participation of KLTI reduced the gastrointestinal reaction (RR 0.79; 95% CI; 0.66\u20130.96; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%, <jats:italic>z<\/jats:italic> = 2.37, <jats:italic>p<\/jats:italic> = 0.018) and renal damage (RR 0.468; 95% CI; 0.23\u20130.945, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%, <jats:italic>z<\/jats:italic> = 2.11, <jats:italic>p<\/jats:italic> = 0.035) caused by chemotherapy drugs, but did not increase other adverse reactions (<jats:italic>p<\/jats:italic> &amp;gt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The efficacy and safety of traditional chemotherapy drugs plus KLTI was superior to traditional chemotherapy drugs alone via intrapleural injection in controlling MPE, which suggested that KLTI can be used to treat MPE. However, a more rigorous RCT should be designed and completed before it is widely recommended.<\/jats:p>","DOI":"10.3389\/fphar.2021.694129","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T05:29:37Z","timestamp":1635917377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.3389","volume":"12","author":[{"given":"Guanghui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruike","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11136-013-0583-6","article-title":"Time to Health-Related Quality of Life Score Deterioration as a Modality of Longitudinal Analysis for Health-Related Quality of Life Studies in Oncology: Do We Need RECIST for Quality of Life to Achieve Standardization","volume":"24","author":"Anota","year":"2015","journal-title":"Qual. Life Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"39355","DOI":"10.1038\/srep39355","article-title":"Evaluation of Efficacy and Safety for Recombinant Human Adenovirus-P53 in the Control of the Malignant Pleural Effusions via Thoracic Perfusion","volume":"6","author":"Biaoxue","year":"2016","journal-title":"Sci. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"113388","DOI":"10.1016\/j.jep.2020.113388","article-title":"Kanglaite Enhances the Efficacy of Cisplatin in Suppression of Hepatocellular Carcinoma via Inhibiting CKLF1 Mediated NF-\u039ab Pathway and Regulating Transporter Mediated Drug Efflux","volume":"264","author":"Chen","year":"2021","journal-title":"J. Ethnopharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ijbiomac.2019.08.018","article-title":"Preparation, Characterization and Anti-diabetic Activity of Polysaccharides from Adlay Seed","volume":"139","author":"Chen","year":"2019","journal-title":"Int. J. Biol. Macromol"},{"key":"B5","first-page":"71","article-title":"Observation on the Efficacy of Cisplatin Combined with Kanglaite Injection in the Treatment of Malignant Pleural Effusion (In Chinese)","volume":"50","author":"Chen","year":"2010","journal-title":"Shandong Med. J."},{"key":"B6","unstructured":"China Food and Drug Administration (CFDA)2019"},{"key":"B7","unstructured":"Kanglaite Injection Phase I Study2019"},{"key":"B8","first-page":"838","article-title":"The Effects of Combination of Coix Seed Extract and Cisplatin on TAM and Expression of HIF-1\u03b1 In Vivo in Lewis Lung Carcinoma","volume":"47","author":"Duan","year":"2018","journal-title":"Iran J. Public Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4065\/83.2.235","article-title":"Recent Advances in the Diagnosis and Management of Malignant Pleural Effusions","volume":"83","author":"Heffner","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"B10","first-page":"35","article-title":"Study on the Effect of Kanglaite Injection on the Function of Human NK Cells (In Chinese)","volume":"49","author":"Huang","year":"2018","journal-title":"Jiangxi J. Traditional Chin. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"153154","DOI":"10.1016\/j.phymed.2019.153154","article-title":"Kanglaite Injection Plus Platinum-Based Chemotherapy for Stage III\/IV Non-small Cell Lung Cancer: A Meta-Analysis of 27 RCTs","volume":"67","author":"Huang","year":"2020","journal-title":"Phytomedicine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3969\/j.issn.1672-4992.2005.02.046","article-title":"Observation on the Efficacy of Kanglaite Combined with Cisplatin in the Treatment of Malignant Pleural Effusion (In Chinese)","volume":"13","author":"Jia","year":"2005","journal-title":"J. Mod. Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3969\/j.issn.1000-1719.2007.05.039","article-title":"Clinical Observation of Pleural Injection of Kanglaite and Cisplatin Combined with Local Hyperthermia in the Treatment of Malignant Pleural Effusion (In Chinese)","volume":"34","author":"Jia","year":"2007","journal-title":"Liaoning J. Traditional Chin. Med."},{"key":"B14","first-page":"418","article-title":"Effects of Erlotinib Combined with Kanglaite on Proliferation, Invasion and JAK2\/STAT3 Signal Pathway of Lung Cancer Cell Line A549 (In Chinese)","volume":"54","author":"Jiang","year":"2019","journal-title":"J. Zhengzhou University(Medical Sciences)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.7754\/clin.lab.2015.150134","article-title":"The Synergistic Mechanism of Pemetrexed Followed by Kanglaite Was Due to KLT Subsequently Inhibiting the Pemetrexed-Activated MAPK Signaling Pathway","volume":"61","author":"Jiang","year":"2015","journal-title":"Clin. Lab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1142\/S0192415X07004825","article-title":"The Water Extract of Adlay Seed (Coix Lachrymajobi Var. Mayuen) Exhibits Anti-obesity Effects through Neuroendocrine Modulation","volume":"35","author":"Kim","year":"2007","journal-title":"Am. J. Chin. Med."},{"key":"B17","first-page":"39","article-title":"Intracavitary Injection of Kanglaite Combined with Cisplatin in the Treatment of Malignant Pleural Effusion (In Chinese)","volume":"32","author":"Lan","year":"2012","journal-title":"Mod. Traditional Chin. Med."},{"key":"B18","first-page":"1052","article-title":"Reticular Meta-Analysis of 8 Kinds of Traditional Chinese Medicine Injection Combined with Cisplatin in the Treatment of Malignant Pleural Effusion (In Chinese)","volume":"39","author":"Li","year":"2019","journal-title":"Chin. J. Hosp. Pharm."},{"key":"B19","first-page":"438","article-title":"Clinical Observation of Kanglaite in the Treatment of Malignant Pleural Effusion in Patients with Non-small Cell Lung Cancer (In Chinese)","volume":"10","author":"Li","year":"2012","journal-title":"Guide China Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.21037\/apm-20-616","article-title":"Efficacy and Safety of Kanglaite Injection Combined with First-Line Platinum-Based Chemotherapy in Patients with Advanced NSCLC: a Systematic Review and Meta-Analysis of 32 RCTs","volume":"9","author":"Li","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"B21","first-page":"387","article-title":"Clinical Observation of 56 Cases of Malignant Pleural Effusion Treated with Kanglaite Combined with Microcatheter (In Chinese)","volume":"5","author":"Li","year":"2005","journal-title":"Chin. Remedies Clin."},{"key":"B22","first-page":"1736","article-title":"Pleural Infusion of Kanglaite Combined with Oxaliplatin in the Treatment of Malignant Pleural Effusion and its Effect on the Expression of RCAS1 and VEGF (In Chinese)","volume":"24","author":"Li","year":"2016","journal-title":"J. Mod. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3779\/j.issn.1009-3419.2006.01.19","article-title":"Combination of GP Regimen and Kanglaite in the Treatment of Advanced Non-small Cell Lung Cancer","volume":"9","author":"Lian","year":"2006","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"B24","doi-asserted-by":"publisher","first-page":"BSR20193319","DOI":"10.1042\/BSR20193319","article-title":"The Clinical Efficacy and Safety of Kanglaite Adjuvant Therapy in the Treatment of Advanced Hepatocellular Carcinoma: A PRISMA-Compliant Meta-Analysis","volume":"39","author":"Liu","year":"2019","journal-title":"Biosci. Rep."},{"key":"B25","first-page":"1758","article-title":"Clinical Observation and Nursing of Kanglaite Combined with Cisplatin Pleural Perfusion to Improve the Quality of Life of Patients with Malignant Pleural Effusion (In Chinese)","volume":"31","author":"Liu","year":"2012","journal-title":"Int. J. Nurs."},{"key":"B26","first-page":"6993","article-title":"Observation on the Efficacy of Docetaxel and Kanglaite Sequential Pleural Perfusion Combined with Hyperthermia in the Treatment of Malignant Pleural Effusion (In Chinese)","volume":"35","author":"Liu","year":"2014","journal-title":"Jilin Med. J."},{"key":"B27","first-page":"967","article-title":"Clinical Study of Pleural Injection of Kanglaite and Arsenite Combined with Hyperthermia in the Treatment of Malignant Pleural Effusion (In Chinese)","volume":"33","author":"Liu","year":"","journal-title":"J. Clin. Res."},{"key":"B28","first-page":"577","article-title":"Effect of Kanglaite on Quality of Life and Immune Function in Patients with Pleural Effusion of Lung Cancer (In Chinese)","volume":"33","author":"Liu","year":"","journal-title":"J. Clin. Res."},{"key":"B29","first-page":"1080","article-title":"Clinical Study of Kanglaite Injection Combined with Carboplatin in the Treatment of Malignant Pleural Effusion in Patients with Non-small Cell Lung Cancer (In Chinese)","volume":"34","author":"Mo","year":"2019","journal-title":"Drugs & Clinic"},{"key":"B30","unstructured":"NCI Dictionary2019"},{"key":"B31","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jep.2012.07.025","article-title":"Antitumor Activity and Immunomodulatory Effects of the Intraperitoneal Administration of Kanglaite In Vivo in Lewis Lung Carcinoma","volume":"143","author":"Pan","year":"2012","journal-title":"J. Ethnopharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/CMAR.S95663","article-title":"Management of Malignant Pleural Effusion: Challenges and Solutions","volume":"9","author":"Penz","year":"2017","journal-title":"Cancer Manag. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/resp.12496","article-title":"Clinical Features and Survival of Lung Cancer Patients with Pleural Effusions","volume":"20","author":"Porcel","year":"2015","journal-title":"Respirology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a Malignant Pleural Effusion: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"B35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the Management of Malignant Pleural Mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur. Respir. J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.7150\/jca.15407","article-title":"A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) Plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer","volume":"8","author":"Schwartzberg","year":"2017","journal-title":"J. Cancer"},{"key":"B37","first-page":"58","article-title":"Study on Anti-tumor Mechanism of Three Main Components of Kanglaite Injection Based on Network Pharmacology (In Chinese)","volume":"36","author":"Wang","year":"2019","journal-title":"Chin. Mod. Appl. Pharm."},{"key":"B38","doi-asserted-by":"publisher","first-page":"111044","DOI":"10.1016\/j.biopha.2020.111044","article-title":"Anticancer Activities of TCM and Their Active Components against Tumor Metastasis","volume":"133","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B39","first-page":"266","article-title":"Observation on the Efficacy of Carboplatin Combined with Kanglaite Hyperthermic Perfusion Chemotherapy in the Treatment of Malignant Abdominal Pleural Effusion (In Chinese)","volume":"25","author":"Wang","year":"2013","journal-title":"Strait Pharm. J."},{"key":"B40","first-page":"22","article-title":"Clinical Observation of Kanglaite Combined with Recombinant Human Interleukin-2 Infusion in the Treatment of Malignant Pleural Effusion (In Chinese)","volume":"15","author":"Wang","year":"2018","journal-title":"Med. Innovation China"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.4161\/cbt.6.12.5168","article-title":"Coix Seed Extract, a Commonly Used Treatment for Cancer in China, Inhibits NFkappaB and Protein Kinase C Signaling","volume":"6","author":"Woo","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"B42","first-page":"4092","article-title":"Efficacy and Mechanism of Coix Seed Injection Combined with Hydroxycamptothecin in the Treatment of Malignant Pleural Effusion in Elderly Patients with Advanced Non-small Cell Lung Cancer (In Chinese)","volume":"31","author":"Xiao","year":"2011","journal-title":"Chin. J. Gerontol."},{"key":"B43","first-page":"130","article-title":"Combination of Cisplatin and Kanglaite in the Treatment of 43 Cases of Malignant Pleural Effusion (In Chinese)","volume":"15","author":"Xie","year":"2000","journal-title":"J. Pract. Oncol."},{"key":"B44","first-page":"239","article-title":"Clinical Observation of Kanglaite Combined with Carboplatin in the Treatment of Malignant Pleural Effusion in Patients with Advanced Lung Cancer (In Chinese)","volume":"9","author":"Xu","year":"2012","journal-title":"World Health Dig."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5928562","DOI":"10.1155\/2016\/5928562","article-title":"The Efficacy of Brucea Javanica Oil Emulsion Injection as Adjunctive Therapy for Advanced Non-small-cell Lung Cancer: a Meta-Analysis","volume":"2016","author":"Xu","year":"2016","journal-title":"Evid. Based Complement. Alternat Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2147\/OTT.S153814","article-title":"Kanglaite Reverses Multidrug Resistance of HCC by Inducing Apoptosis and Cell Cycle Arrest via PI3K\/AKT Pathway","volume":"11","author":"Yang","year":"2018","journal-title":"Onco Targets Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3969\/j.issn.1002-3070.2005.04.019","article-title":"Clinical Observation of Kanglaite Combined with Cisplatin in the Treatment of Malignant Pleural Effusion (In Chinese)","volume":"19","author":"Yang","year":"2005","journal-title":"Pract. Oncol. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"S413","DOI":"10.3978\/j.issn.2072-1439.2013.09.04","article-title":"Malignant Pleural Effusion and Algorithm Management","volume":"5","author":"Zarogoulidis","year":"2013","journal-title":"J. Thorac. Dis."},{"key":"B49","first-page":"278","article-title":"Study on the Efficacy and Safety of Kanglaite Combined with Cisplatin Pleural Perfusion in the Treatment of Malignant Pleural Effusion (In Chinese)","volume":"20","author":"Zhang","year":"2009","journal-title":"Traditional Chin. Drug Res. Clin. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"609705","DOI":"10.3389\/fimmu.2020.609705","article-title":"Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3969\/j.issn.1673-5269.2002.06.034","article-title":"Curative Effect Observation and Nursing of Treatment of Malignant Hy Drothorax with KLTI and ADM, DDP (In Chinese)","volume":"9","author":"Zhao","year":"2002","journal-title":"Chin. J. Cancer Prev. Treat."},{"key":"B52","first-page":"77","article-title":"Study on the Effect of Coix Seed Oil on Immune Function in Mice (In Chinese)","volume":"43","author":"Zhou","year":"2018","journal-title":"China Oils and Fats"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.694129\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T05:30:10Z","timestamp":1635917410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.694129\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,3]]},"references-count":52,"alternative-id":["10.3389\/fphar.2021.694129"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.694129","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2021,11,3]]},"article-number":"694129"}}